INVA
Innoviva Inc. INVA
$22.53
▲ +1.34% 24H
4.6511.9719.2926.6133.922004-102010-032015-082021-012026-06

About

Innoviva Inc. is an innovative pharmaceutical company, focusing primarily on managing royalty portfolios that originate from collaborations with external partners. This asset plays a significant role in the healthcare sector, specifically within the pharmaceuticals and biotechnology industries. The company is involved

SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees159
TickerINVA

Statistics

Market Cap$1.66B
Revenue (TTM)$411.3M
Net Income$271.2M
Net Margin65.9%
EPS$3.30
P/E3.58
P/S3.94
P/B1.23
EV/EBITDA7.35
ROE50.7%
Dividend Yield4.43%
Price$22.53

Data: Twelve Data · Revenue = mcap / P/S

Innoviva Inc. (INVA) — Market Cap, Revenue, Net Income, P/E | companiesbycap